EP Patent

EP2474521B1 — High purity degree 2-[4-(3- and 2-fluorobenzyloxy)benzylamino]propanamides for use as medicaments and pharmaceutical formulations containing them

Assigned to Newron Pharmaceuticals SpA · Expires 2016-08-10 · 10y expired

What this patent protects

Patent listed against safinamide-mesylate.

Drugs covered by this patent

safinamide-mesylate (SAFINAMIDE MESYLATE)

Patent Metadata

Patent number: EP2474521B1
Jurisdiction: EP
Classification: —
Expires: 2016-08-10
Drug substance claim: No
Drug product claim: No
Assignee: Newron Pharmaceuticals SpA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.